Is Pds Biotechnology Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: PDSB) stock is to Strong Buy PDSB stock.
Out of 3 analysts, 1 (33.33%) are recommending PDSB as a Strong Buy, 2 (66.67%) are recommending PDSB as a Buy, 0 (0%) are recommending PDSB as a Hold, 0 (0%) are recommending PDSB as a Sell, and 0 (0%) are recommending PDSB as a Strong Sell.
What is PDSB's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: PDSB) forecast ROE is N/A, which is considered weak.
What is PDSB's Price Target?
According to 3 Wall Street analysts that have issued a 1 year PDSB price target, the average PDSB price target is $19.00, with the highest PDSB stock price forecast at $24.00 and the lowest PDSB stock price forecast at $12.00.
On average, Wall Street analysts predict that Pds Biotechnology's share price could reach $19.00 by May 26, 2024. The average Pds Biotechnology stock price prediction forecasts a potential upside of 101.7% from the current PDSB share price of $9.42.
What is PDSB's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: PDSB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.